{
  "company_number": "10025982",
  "name": "G & C Pharma Limited",
  "url": "/company/10025982",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2016-02-25",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "46460",
      "description": "Wholesale of pharmaceutical goods",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/46460"
    }
  ],
  "registered_address": {
    "id": 991369,
    "url": "/address/991369",
    "line1": "HIGH STREET PHARMACY",
    "line2": "88 HIGH STREET",
    "post_town": "BARRY",
    "county": "VALE OF GLAMORGAN",
    "country": "WALES",
    "postcode": "CF62 7DX"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10025982",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-06-30",
    "last_made_up": "2025-09-30",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/10025982/accounts/2025-09-30",
        "made_up_date": "2025-09-30",
        "period_start": "2025-09-30",
        "period_end": "2025-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "14.00",
        "tangible_fixed_assets": "2582318.00",
        "debtors": "355627.00",
        "cash_bank_in_hand": "132024.00",
        "current_assets": "538929.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-723294.00",
        "total_assets_less_current_liabilities": "1859024.00",
        "net_assets_liabilities": "1058985.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2026.zip"
      },
      {
        "url": "/company/10025982/accounts/2024-09-30",
        "made_up_date": "2024-09-30",
        "period_start": "2024-09-30",
        "period_end": "2024-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "15.00",
        "tangible_fixed_assets": "2637244.00",
        "debtors": "372312.00",
        "cash_bank_in_hand": "66647.00",
        "current_assets": "535728.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-696083.00",
        "total_assets_less_current_liabilities": "1941161.00",
        "net_assets_liabilities": "999839.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2025.zip"
      },
      {
        "url": "/company/10025982/accounts/2023-09-30",
        "made_up_date": "2023-09-30",
        "period_start": "2023-09-30",
        "period_end": "2023-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "13.00",
        "tangible_fixed_assets": "2692850.00",
        "debtors": "223411.00",
        "cash_bank_in_hand": "172373.00",
        "current_assets": "523436.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-622362.00",
        "total_assets_less_current_liabilities": "2070488.00",
        "net_assets_liabilities": "921360.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2024.zip"
      },
      {
        "url": "/company/10025982/accounts/2022-09-30",
        "made_up_date": "2022-09-30",
        "period_start": "2022-09-30",
        "period_end": "2022-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "11.00",
        "tangible_fixed_assets": "2673190.00",
        "debtors": "191673.00",
        "cash_bank_in_hand": "169656.00",
        "current_assets": "461286.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-655875.00",
        "total_assets_less_current_liabilities": "2017315.00",
        "net_assets_liabilities": "764924.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2023.zip"
      },
      {
        "url": "/company/10025982/accounts/2021-09-30",
        "made_up_date": "2021-09-30",
        "period_start": "2020-10-01",
        "period_end": "2021-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "10.00",
        "tangible_fixed_assets": "2691958.00",
        "debtors": "264199.00",
        "cash_bank_in_hand": "35719.00",
        "current_assets": "359672.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-557656.00",
        "total_assets_less_current_liabilities": "2134302.00",
        "net_assets_liabilities": "754017.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "121035.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2022.zip"
      },
      {
        "url": "/company/10025982/accounts/2020-09-30",
        "made_up_date": "2020-09-30",
        "period_start": "2019-10-01",
        "period_end": "2020-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "2732940.00",
        "debtors": "241739.00",
        "cash_bank_in_hand": "27255.00",
        "current_assets": "327833.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-274412.00",
        "total_assets_less_current_liabilities": "2458528.00",
        "net_assets_liabilities": "708982.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "687221.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2021.zip"
      },
      {
        "url": "/company/10025982/accounts/2019-09-30",
        "made_up_date": "2019-09-30",
        "period_start": "2018-10-01",
        "period_end": "2019-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "464024.00",
        "debtors": "159605.00",
        "cash_bank_in_hand": "82143.00",
        "current_assets": "280213.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-126872.00",
        "total_assets_less_current_liabilities": "337152.00",
        "net_assets_liabilities": "107761.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "59307.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2020.zip"
      },
      {
        "url": "/company/10025982/accounts/2018-09-30",
        "made_up_date": "2018-09-30",
        "period_start": "2017-10-01",
        "period_end": "2018-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "5.00",
        "tangible_fixed_assets": "492225.00",
        "debtors": "160546.00",
        "cash_bank_in_hand": "72252.00",
        "current_assets": "284430.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-150688.00",
        "total_assets_less_current_liabilities": "341537.00",
        "net_assets_liabilities": "78644.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "80648.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2019.zip"
      },
      {
        "url": "/company/10025982/accounts/2017-09-30",
        "made_up_date": "2017-09-30",
        "period_start": "2016-10-01",
        "period_end": "2017-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": false,
        "average_employees": "3.00",
        "tangible_fixed_assets": "517686.00",
        "debtors": "73942.00",
        "cash_bank_in_hand": "108698.00",
        "current_assets": "217640.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-204190.00",
        "total_assets_less_current_liabilities": "313496.00",
        "net_assets_liabilities": "29996.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": "62196.00",
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-March2018.zip"
      },
      {
        "url": "/company/10025982/accounts/2016-09-30",
        "made_up_date": "2016-09-30",
        "period_start": "2016-09-30",
        "period_end": "2016-09-30",
        "entity_name": "G & C Pharma Limited",
        "dormant": true,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "100.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": null,
        "total_assets_less_current_liabilities": null,
        "net_assets_liabilities": "100.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "xml",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-April2017.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10025982/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-02-23",
    "last_made_up": "2026-02-09"
  },
  "officers": [],
  "psc": [
    {
      "name": "Ms Gwawr Elis Davies Jones",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/1799260",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "Wales",
      "source": "snapshot"
    },
    {
      "name": "Mrs Claire Harris",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/959946",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "Wales",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T05:26:26.711035+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}